MedX Health Corp (CVE:MDX – Get Free Report)’s share price fell 20% on Thursday. The company traded as low as C$0.04 and last traded at C$0.04. Approximately 276,100 shares traded hands during mid-day trading, an increase of 221% from the average daily volume of 86,096 shares. The stock had previously closed at C$0.05.
MedX Health Price Performance
The business has a 50-day moving average of C$0.05 and a 200-day moving average of C$0.05. The company has a market capitalization of C$13.12 million, a P/E ratio of -2.00 and a beta of 0.21.
About MedX Health
MedX Health Corp develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market. It operates DermSecure telemedicine platform that enables the web-based operation of its SIAscopy scanning technology and allows the company to deploy its technology in networks of third-party locations from which patients' mole and lesion images along with other relevant patient information can be connected to specialist physicians for remote assessment.
Recommended Stories
- Five stocks we like better than MedX Health
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for MedX Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedX Health and related companies with MarketBeat.com's FREE daily email newsletter.
